Pharmaceutical Discount Agreements for IKK classic
IKK classic is entering into non-exclusive discount agreements for various active ingredients from May 2026 to April 2028. The goal is to reduce pharmaceutical costs.
CONTRACTING AUTHORITY
Name
IKK classic
City
Dresden
Country
DE
CLASSIFICATION
Procedure Type
Open Procedure
Contract Type
Supplies
Main CPV
33600000, Pharmaceutical products.
LOTS (26)
Alectinib
Amifampridin
Bisacodyl
Candesartan und Amlodipin (90 Stück)
Clindamycin und Benzoylperoxid
Codein
Encorafenib
Fenoterol und Ipratropiumbromid
Glycopyrroniumbromid
Hydroxycarbamid (100 mg und 1000 mg)
Imiglucerase
Interferon beta-1a (Rebif®)
Lacosamid (Infusionslösung)
Moxifloxacin (Augentropfen)
Nintedanib
Ribociclib
Romiplostim
Rufinamid
Sirolimus
Tafamidis
Triptorelin
Eculizumab
Caspofungin
Folsäure
Levomethadon
Salmeterol und Fluticason (Inhalationspulver)
ADDITIONAL DETAILS
Legal Basis
32014L0024
DEADLINES & TIMELINE
Submission Deadline
656 days remaining(LOT-0001)
Published